Selhub J - Search Results

1

Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk.

Tofler GH, D'Agostino RB, Jacques PF, Bostom AG, Wilson PW, Lipinska I, Mittleman MA, Selhub J. Tofler GH, et al. Among authors: selhub j. Thromb Haemost. 2002 Nov;88(5):799-804. Thromb Haemost. 2002. PMID: 12428097

2

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Seshadri S, et al. Among authors: selhub j. N Engl J Med. 2002 Feb 14;346(7):476-83. doi: 10.1056/NEJMoa011613. N Engl J Med. 2002. PMID: 11844848 Free article.

3

Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.

Bostom AG, Jacques PF, Liaugaudas G, Rogers G, Rosenberg IH, Selhub J. Bostom AG, et al. Among authors: selhub j. Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):488-91. doi: 10.1161/hq0302.105369. Arterioscler Thromb Vasc Biol. 2002. PMID: 11884295 Clinical Trial.

4

Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction.

Vasan RS, Beiser A, D'Agostino RB, Levy D, Selhub J, Jacques PF, Rosenberg IH, Wilson PW. Vasan RS, et al. Among authors: selhub j. JAMA. 2003 Mar 12;289(10):1251-7. doi: 10.1001/jama.289.10.1251. JAMA. 2003. PMID: 12633186

5

Multiple biomarkers for the prediction of first major cardiovascular events and death.

Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. Wang TJ, et al. Among authors: selhub j. N Engl J Med. 2006 Dec 21;355(25):2631-9. doi: 10.1056/NEJMoa055373. N Engl J Med. 2006. PMID: 17182988 Free article.

6

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.

Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ. Wilson PW, et al. Among authors: selhub j. Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):92-7. doi: 10.1161/CIRCOUTCOMES.108.831198. Epub 2008 Nov 9. Circ Cardiovasc Qual Outcomes. 2008. PMID: 20031795 Free PMC article.

7

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.

Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, Dworkin L, Rosenberg IH. Bostom AG, et al. Among authors: selhub j. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2554-8. doi: 10.1161/01.atv.17.11.2554. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409227

8

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF, Wilson PW. Bostom AG, et al. Among authors: selhub j. Arch Intern Med. 1999 May 24;159(10):1077-80. doi: 10.1001/archinte.159.10.1077. Arch Intern Med. 1999. PMID: 10335684

9

Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study.

Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA. Bostom AG, et al. Among authors: selhub j. Ann Intern Med. 1999 Sep 7;131(5):352-5. doi: 10.7326/0003-4819-131-5-199909070-00006. Ann Intern Med. 1999. PMID: 10475888

10

The kidney and homocysteine metabolism.

Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH. Friedman AN, et al. Among authors: selhub j. J Am Soc Nephrol. 2001 Oct;12(10):2181-2189. doi: 10.1681/ASN.V12102181. J Am Soc Nephrol. 2001. PMID: 11562419 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters